Avoid Mishaps With SGLT2 Inhibitors
September 2022
More inpatients will get SGLT2 inhibitors...canagliflozin, dapagliflozin, empagliflozin, or ertugliflozin.
These meds were originally approved for type 2 diabetes. But now they’re also recommended for certain patients with heart failure.
Avoid mishaps with SGLT2 inhibitors as use increases.Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote